Global Veterinary Vaccines Market Insights, Forecast to 2028

Global Veterinary Vaccines Market Insights, Forecast to 2028

Table of Contents
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Veterinary Vaccines Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Inactivated Vaccines
1.2.3 Live Attenuated Vaccines
1.2.4 Conjugate Vaccines
1.2.5 Toxoid Vaccines
1.2.6 Recombinant Vaccines
1.2.7 DNA Vaccines
1.2.8 Others
1.3 Market by Application
1.3.1 Global Veterinary Vaccines Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Veterinary Clinic
1.3.3 Veterinary Hospital
1.3.4 Veterinary Research Institute
1.3.5 Retail Pharmacy
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Veterinary Vaccines Market Perspective (2017-2028)
2.2 Veterinary Vaccines Growth Trends by Region
2.2.1 Veterinary Vaccines Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Veterinary Vaccines Historic Market Size by Region (2017-2022)
2.2.3 Veterinary Vaccines Forecasted Market Size by Region (2023-2028)
2.3 Veterinary Vaccines Market Dynamics
2.3.1 Veterinary Vaccines Industry Trends
2.3.2 Veterinary Vaccines Market Drivers
2.3.3 Veterinary Vaccines Market Challenges
2.3.4 Veterinary Vaccines Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Veterinary Vaccines Players by Revenue
3.1.1 Global Top Veterinary Vaccines Players by Revenue (2017-2022)
3.1.2 Global Veterinary Vaccines Revenue Market Share by Players (2017-2022)
3.2 Global Veterinary Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Veterinary Vaccines Revenue
3.4 Global Veterinary Vaccines Market Concentration Ratio
3.4.1 Global Veterinary Vaccines Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Veterinary Vaccines Revenue in 2021
3.5 Veterinary Vaccines Key Players Head office and Area Served
3.6 Key Players Veterinary Vaccines Product Solution and Service
3.7 Date of Enter into Veterinary Vaccines Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Veterinary Vaccines Breakdown Data by Type
4.1 Global Veterinary Vaccines Historic Market Size by Type (2017-2022)
4.2 Global Veterinary Vaccines Forecasted Market Size by Type (2023-2028)
5 Veterinary Vaccines Breakdown Data by Application
5.1 Global Veterinary Vaccines Historic Market Size by Application (2017-2022)
5.2 Global Veterinary Vaccines Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Veterinary Vaccines Market Size (2017-2028)
6.2 North America Veterinary Vaccines Market Size by Type
6.2.1 North America Veterinary Vaccines Market Size by Type (2017-2022)
6.2.2 North America Veterinary Vaccines Market Size by Type (2023-2028)
6.2.3 North America Veterinary Vaccines Market Share by Type (2017-2028)
6.3 North America Veterinary Vaccines Market Size by Application
6.3.1 North America Veterinary Vaccines Market Size by Application (2017-2022)
6.3.2 North America Veterinary Vaccines Market Size by Application (2023-2028)
6.3.3 North America Veterinary Vaccines Market Share by Application (2017-2028)
6.4 North America Veterinary Vaccines Market Size by Country
6.4.1 North America Veterinary Vaccines Market Size by Country (2017-2022)
6.4.2 North America Veterinary Vaccines Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Veterinary Vaccines Market Size (2017-2028)
7.2 Europe Veterinary Vaccines Market Size by Type
7.2.1 Europe Veterinary Vaccines Market Size by Type (2017-2022)
7.2.2 Europe Veterinary Vaccines Market Size by Type (2023-2028)
7.2.3 Europe Veterinary Vaccines Market Share by Type (2017-2028)
7.3 Europe Veterinary Vaccines Market Size by Application
7.3.1 Europe Veterinary Vaccines Market Size by Application (2017-2022)
7.3.2 Europe Veterinary Vaccines Market Size by Application (2023-2028)
7.3.3 Europe Veterinary Vaccines Market Share by Application (2017-2028)
7.4 Europe Veterinary Vaccines Market Size by Country
7.4.1 Europe Veterinary Vaccines Market Size by Country (2017-2022)
7.4.2 Europe Veterinary Vaccines Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Veterinary Vaccines Market Size (2017-2028)
8.2 Asia-Pacific Veterinary Vaccines Market Size by Type
8.2.1 Asia-Pacific Veterinary Vaccines Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Veterinary Vaccines Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Veterinary Vaccines Market Share by Type (2017-2028)
8.3 Asia-Pacific Veterinary Vaccines Market Size by Application
8.3.1 Asia-Pacific Veterinary Vaccines Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Veterinary Vaccines Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Veterinary Vaccines Market Share by Application (2017-2028)
8.4 Asia-Pacific Veterinary Vaccines Market Size by Region
8.4.1 Asia-Pacific Veterinary Vaccines Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Veterinary Vaccines Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Veterinary Vaccines Market Size (2017-2028)
9.2 Latin America Veterinary Vaccines Market Size by Type
9.2.1 Latin America Veterinary Vaccines Market Size by Type (2017-2022)
9.2.2 Latin America Veterinary Vaccines Market Size by Type (2023-2028)
9.2.3 Latin America Veterinary Vaccines Market Share by Type (2017-2028)
9.3 Latin America Veterinary Vaccines Market Size by Application
9.3.1 Latin America Veterinary Vaccines Market Size by Application (2017-2022)
9.3.2 Latin America Veterinary Vaccines Market Size by Application (2023-2028)
9.3.3 Latin America Veterinary Vaccines Market Share by Application (2017-2028)
9.4 Latin America Veterinary Vaccines Market Size by Country
9.4.1 Latin America Veterinary Vaccines Market Size by Country (2017-2022)
9.4.2 Latin America Veterinary Vaccines Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Veterinary Vaccines Market Size (2017-2028)
10.2 Middle East & Africa Veterinary Vaccines Market Size by Type
10.2.1 Middle East & Africa Veterinary Vaccines Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Veterinary Vaccines Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Veterinary Vaccines Market Share by Type (2017-2028)
10.3 Middle East & Africa Veterinary Vaccines Market Size by Application
10.3.1 Middle East & Africa Veterinary Vaccines Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Veterinary Vaccines Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Veterinary Vaccines Market Share by Application (2017-2028)
10.4 Middle East & Africa Veterinary Vaccines Market Size by Country
10.4.1 Middle East & Africa Veterinary Vaccines Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Veterinary Vaccines Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Elanco
11.1.1 Elanco Company Details
11.1.2 Elanco Business Overview
11.1.3 Elanco Veterinary Vaccines Introduction
11.1.4 Elanco Revenue in Veterinary Vaccines Business (2017-2022)
11.1.5 Elanco Recent Developments
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Merck Business Overview
11.2.3 Merck Veterinary Vaccines Introduction
11.2.4 Merck Revenue in Veterinary Vaccines Business (2017-2022)
11.2.5 Merck Recent Developments
11.3 Merial
11.3.1 Merial Company Details
11.3.2 Merial Business Overview
11.3.3 Merial Veterinary Vaccines Introduction
11.3.4 Merial Revenue in Veterinary Vaccines Business (2017-2022)
11.3.5 Merial Recent Developments
11.4 Zoetis
11.4.1 Zoetis Company Details
11.4.2 Zoetis Business Overview
11.4.3 Zoetis Veterinary Vaccines Introduction
11.4.4 Zoetis Revenue in Veterinary Vaccines Business (2017-2022)
11.4.5 Zoetis Recent Developments
11.5 Advaxis
11.5.1 Advaxis Company Details
11.5.2 Advaxis Business Overview
11.5.3 Advaxis Veterinary Vaccines Introduction
11.5.4 Advaxis Revenue in Veterinary Vaccines Business (2017-2022)
11.5.5 Advaxis Recent Developments
11.6 AmpliPhi Biosciences
11.6.1 AmpliPhi Biosciences Company Details
11.6.2 AmpliPhi Biosciences Business Overview
11.6.3 AmpliPhi Biosciences Veterinary Vaccines Introduction
11.6.4 AmpliPhi Biosciences Revenue in Veterinary Vaccines Business (2017-2022)
11.6.5 AmpliPhi Biosciences Recent Developments
11.7 Aratana Therapeutics
11.7.1 Aratana Therapeutics Company Details
11.7.2 Aratana Therapeutics Business Overview
11.7.3 Aratana Therapeutics Veterinary Vaccines Introduction
11.7.4 Aratana Therapeutics Revenue in Veterinary Vaccines Business (2017-2022)
11.7.5 Aratana Therapeutics Recent Developments
11.8 ARKO Labs
11.8.1 ARKO Labs Company Details
11.8.2 ARKO Labs Business Overview
11.8.3 ARKO Labs Veterinary Vaccines Introduction
11.8.4 ARKO Labs Revenue in Veterinary Vaccines Business (2017-2022)
11.8.5 ARKO Labs Recent Developments
11.9 Bayer
11.9.1 Bayer Company Details
11.9.2 Bayer Business Overview
11.9.3 Bayer Veterinary Vaccines Introduction
11.9.4 Bayer Revenue in Veterinary Vaccines Business (2017-2022)
11.9.5 Bayer Recent Developments
11.10 CanFel Therapeutics
11.10.1 CanFel Therapeutics Company Details
11.10.2 CanFel Therapeutics Business Overview
11.10.3 CanFel Therapeutics Veterinary Vaccines Introduction
11.10.4 CanFel Therapeutics Revenue in Veterinary Vaccines Business (2017-2022)
11.10.5 CanFel Therapeutics Recent Developments
11.11 Ceva Animal Health
11.11.1 Ceva Animal Health Company Details
11.11.2 Ceva Animal Health Business Overview
11.11.3 Ceva Animal Health Veterinary Vaccines Introduction
11.11.4 Ceva Animal Health Revenue in Veterinary Vaccines Business (2017-2022)
11.11.5 Ceva Animal Health Recent Developments
11.12 Colorado Serum
11.12.1 Colorado Serum Company Details
11.12.2 Colorado Serum Business Overview
11.12.3 Colorado Serum Veterinary Vaccines Introduction
11.12.4 Colorado Serum Revenue in Veterinary Vaccines Business (2017-2022)
11.12.5 Colorado Serum Recent Developments
11.13 Epitopix
11.13.1 Epitopix Company Details
11.13.2 Epitopix Business Overview
11.13.3 Epitopix Veterinary Vaccines Introduction
11.13.4 Epitopix Revenue in Veterinary Vaccines Business (2017-2022)
11.13.5 Epitopix Recent Developments
11.14 Genus
11.14.1 Genus Company Details
11.14.2 Genus Business Overview
11.14.3 Genus Veterinary Vaccines Introduction
11.14.4 Genus Revenue in Veterinary Vaccines Business (2017-2022)
11.14.5 Genus Recent Developments
11.15 Hygieia Biological Laboratories
11.15.1 Hygieia Biological Laboratories Company Details
11.15.2 Hygieia Biological Laboratories Business Overview
11.15.3 Hygieia Biological Laboratories Veterinary Vaccines Introduction
11.15.4 Hygieia Biological Laboratories Revenue in Veterinary Vaccines Business (2017-2022)
11.15.5 Hygieia Biological Laboratories Recent Developments
11.16 ImmuCell
11.16.1 ImmuCell Company Details
11.16.2 ImmuCell Business Overview
11.16.3 ImmuCell Veterinary Vaccines Introduction
11.16.4 ImmuCell Revenue in Veterinary Vaccines Business (2017-2022)
11.16.5 ImmuCell Recent Developments
11.17 Nexvet
11.17.1 Nexvet Company Details
11.17.2 Nexvet Business Overview
11.17.3 Nexvet Veterinary Vaccines Introduction
11.17.4 Nexvet Revenue in Veterinary Vaccines Business (2017-2022)
11.17.5 Nexvet Recent Developments
11.18 Nuovo Biologics
11.18.1 Nuovo Biologics Company Details
11.18.2 Nuovo Biologics Business Overview
11.18.3 Nuovo Biologics Veterinary Vaccines Introduction
11.18.4 Nuovo Biologics Revenue in Veterinary Vaccines Business (2017-2022)
11.18.5 Nuovo Biologics Recent Developments
11.19 UBI
11.19.1 UBI Company Details
11.19.2 UBI Business Overview
11.19.3 UBI Veterinary Vaccines Introduction
11.19.4 UBI Revenue in Veterinary Vaccines Business (2017-2022)
11.19.5 UBI Recent Developments
11.20 Valneva
11.20.1 Valneva Company Details
11.20.2 Valneva Business Overview
11.20.3 Valneva Veterinary Vaccines Introduction
11.20.4 Valneva Revenue in Veterinary Vaccines Business (2017-2022)
11.20.5 Valneva Recent Developments
11.21 Vetoquinol
11.21.1 Vetoquinol Company Details
11.21.2 Vetoquinol Business Overview
11.21.3 Vetoquinol Veterinary Vaccines Introduction
11.21.4 Vetoquinol Revenue in Veterinary Vaccines Business (2017-2022)
11.21.5 Vetoquinol Recent Developments
11.22 Virbac
11.22.1 Virbac Company Details
11.22.2 Virbac Business Overview
11.22.3 Virbac Veterinary Vaccines Introduction
11.22.4 Virbac Revenue in Veterinary Vaccines Business (2017-2022)
11.22.5 Virbac Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Veterinary Vaccines Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Inactivated Vaccines
Table 3. Key Players of Live Attenuated Vaccines
Table 4. Key Players of Conjugate Vaccines
Table 5. Key Players of Toxoid Vaccines
Table 6. Key Players of Recombinant Vaccines
Table 7. Key Players of DNA Vaccines
Table 8. Key Players of Others
Table 9. Global Veterinary Vaccines Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 10. Global Veterinary Vaccines Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 11. Global Veterinary Vaccines Market Size by Region (2017-2022) & (US$ Million)
Table 12. Global Veterinary Vaccines Market Share by Region (2017-2022)
Table 13. Global Veterinary Vaccines Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 14. Global Veterinary Vaccines Market Share by Region (2023-2028)
Table 15. Veterinary Vaccines Market Trends
Table 16. Veterinary Vaccines Market Drivers
Table 17. Veterinary Vaccines Market Challenges
Table 18. Veterinary Vaccines Market Restraints
Table 19. Global Veterinary Vaccines Revenue by Players (2017-2022) & (US$ Million)
Table 20. Global Veterinary Vaccines Revenue Share by Players (2017-2022)
Table 21. Global Top Veterinary Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Veterinary Vaccines as of 2021)
Table 22. Ranking of Global Top Veterinary Vaccines Companies by Revenue (US$ Million) in 2021
Table 23. Global 5 Largest Players Market Share by Veterinary Vaccines Revenue (CR5 and HHI) & (2017-2022)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Veterinary Vaccines Product Solution and Service
Table 26. Date of Enter into Veterinary Vaccines Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Veterinary Vaccines Market Size by Type (2017-2022) & (US$ Million)
Table 29. Global Veterinary Vaccines Revenue Market Share by Type (2017-2022)
Table 30. Global Veterinary Vaccines Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 31. Global Veterinary Vaccines Revenue Market Share by Type (2023-2028)
Table 32. Global Veterinary Vaccines Market Size by Application (2017-2022) & (US$ Million)
Table 33. Global Veterinary Vaccines Revenue Share by Application (2017-2022)
Table 34. Global Veterinary Vaccines Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 35. Global Veterinary Vaccines Revenue Share by Application (2023-2028)
Table 36. North America Veterinary Vaccines Market Size by Type (2017-2022) & (US$ Million)
Table 37. North America Veterinary Vaccines Market Size by Type (2023-2028) & (US$ Million)
Table 38. North America Veterinary Vaccines Market Size by Application (2017-2022) & (US$ Million)
Table 39. North America Veterinary Vaccines Market Size by Application (2023-2028) & (US$ Million)
Table 40. North America Veterinary Vaccines Market Size by Country (2017-2022) & (US$ Million)
Table 41. North America Veterinary Vaccines Market Size by Country (2023-2028) & (US$ Million)
Table 42. Europe Veterinary Vaccines Market Size by Type (2017-2022) & (US$ Million)
Table 43. Europe Veterinary Vaccines Market Size by Type (2023-2028) & (US$ Million)
Table 44. Europe Veterinary Vaccines Market Size by Application (2017-2022) & (US$ Million)
Table 45. Europe Veterinary Vaccines Market Size by Application (2023-2028) & (US$ Million)
Table 46. Europe Veterinary Vaccines Market Size by Country (2017-2022) & (US$ Million)
Table 47. Europe Veterinary Vaccines Market Size by Country (2023-2028) & (US$ Million)
Table 48. Asia Pacific Veterinary Vaccines Market Size by Type (2017-2022) & (US$ Million)
Table 49. Asia Pacific Veterinary Vaccines Market Size by Type (2023-2028) & (US$ Million)
Table 50. Asia Pacific Veterinary Vaccines Market Size by Application (2017-2022) & (US$ Million)
Table 51. Asia Pacific Veterinary Vaccines Market Size by Application (2023-2028) & (US$ Million)
Table 52. Asia Pacific Veterinary Vaccines Market Size by Region (2017-2022) & (US$ Million)
Table 53. Asia Pacific Veterinary Vaccines Market Size by Region (2023-2028) & (US$ Million)
Table 54. Latin America Veterinary Vaccines Market Size by Type (2017-2022) & (US$ Million)
Table 55. Latin America Veterinary Vaccines Market Size by Type (2023-2028) & (US$ Million)
Table 56. Latin America Veterinary Vaccines Market Size by Application (2017-2022) & (US$ Million)
Table 57. Latin America Veterinary Vaccines Market Size by Application (2023-2028) & (US$ Million)
Table 58. Latin America Veterinary Vaccines Market Size by Country (2017-2022) & (US$ Million)
Table 59. Latin America Veterinary Vaccines Market Size by Country (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Veterinary Vaccines Market Size by Type (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Veterinary Vaccines Market Size by Type (2023-2028) & (US$ Million)
Table 62. Middle East and Africa Veterinary Vaccines Market Size by Application (2017-2022) & (US$ Million)
Table 63. Middle East and Africa Veterinary Vaccines Market Size by Application (2023-2028) & (US$ Million)
Table 64. Middle East and Africa Veterinary Vaccines Market Size by Country (2017-2022) & (US$ Million)
Table 65. Middle East and Africa Veterinary Vaccines Market Size by Country (2023-2028) & (US$ Million)
Table 66. Elanco Company Details
Table 67. Elanco Business Overview
Table 68. Elanco Veterinary Vaccines Product
Table 69. Elanco Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million)
Table 70. Elanco Recent Developments
Table 71. Merck Company Details
Table 72. Merck Business Overview
Table 73. Merck Veterinary Vaccines Product
Table 74. Merck Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million)
Table 75. Merck Recent Developments
Table 76. Merial Company Details
Table 77. Merial Business Overview
Table 78. Merial Veterinary Vaccines Product
Table 79. Merial Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million)
Table 80. Merial Recent Developments
Table 81. Zoetis Company Details
Table 82. Zoetis Business Overview
Table 83. Zoetis Veterinary Vaccines Product
Table 84. Zoetis Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million)
Table 85. Zoetis Recent Developments
Table 86. Advaxis Company Details
Table 87. Advaxis Business Overview
Table 88. Advaxis Veterinary Vaccines Product
Table 89. Advaxis Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million)
Table 90. Advaxis Recent Developments
Table 91. AmpliPhi Biosciences Company Details
Table 92. AmpliPhi Biosciences Business Overview
Table 93. AmpliPhi Biosciences Veterinary Vaccines Product
Table 94. AmpliPhi Biosciences Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million)
Table 95. AmpliPhi Biosciences Recent Developments
Table 96. Aratana Therapeutics Company Details
Table 97. Aratana Therapeutics Business Overview
Table 98. Aratana Therapeutics Veterinary Vaccines Product
Table 99. Aratana Therapeutics Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million)
Table 100. Aratana Therapeutics Recent Developments
Table 101. ARKO Labs Company Details
Table 102. ARKO Labs Business Overview
Table 103. ARKO Labs Veterinary Vaccines Product
Table 104. ARKO Labs Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million)
Table 105. ARKO Labs Recent Developments
Table 106. Bayer Company Details
Table 107. Bayer Business Overview
Table 108. Bayer Veterinary Vaccines Product
Table 109. Bayer Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million)
Table 110. Bayer Recent Developments
Table 111. CanFel Therapeutics Company Details
Table 112. CanFel Therapeutics Business Overview
Table 113. CanFel Therapeutics Veterinary Vaccines Product
Table 114. CanFel Therapeutics Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million)
Table 115. CanFel Therapeutics Recent Developments
Table 116. Ceva Animal Health Company Details
Table 117. Ceva Animal Health Business Overview
Table 118. Ceva Animal Health Veterinary Vaccines Product
Table 119. Ceva Animal Health Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million)
Table 120. Ceva Animal Health Recent Developments
Table 121. Colorado Serum Company Details
Table 122. Colorado Serum Business Overview
Table 123. Colorado Serum Veterinary Vaccines Product
Table 124. Colorado Serum Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million)
Table 125. Colorado Serum Recent Developments
Table 126. Epitopix Company Details
Table 127. Epitopix Business Overview
Table 128. Epitopix Veterinary Vaccines Product
Table 129. Epitopix Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million)
Table 130. Epitopix Recent Developments
Table 131. Genus Company Details
Table 132. Genus Business Overview
Table 133. Genus Veterinary Vaccines Product
Table 134. Genus Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million)
Table 135. Genus Recent Developments
Table 136. Hygieia Biological Laboratories Company Details
Table 137. Hygieia Biological Laboratories Business Overview
Table 138. Hygieia Biological Laboratories Veterinary Vaccines Product
Table 139. Hygieia Biological Laboratories Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million)
Table 140. Hygieia Biological Laboratories Recent Developments
Table 141. ImmuCell Company Details
Table 142. ImmuCell Business Overview
Table 143. ImmuCell Veterinary Vaccines Product
Table 144. ImmuCell Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million)
Table 145. ImmuCell Recent Developments
Table 146. Nexvet Company Details
Table 147. Nexvet Business Overview
Table 148. Nexvet Veterinary Vaccines Product
Table 149. Nexvet Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million)
Table 150. Nexvet Recent Developments
Table 151. Nuovo Biologics Company Details
Table 152. Nuovo Biologics Business Overview
Table 153. Nuovo Biologics Veterinary Vaccines Product
Table 154. Nuovo Biologics Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million)
Table 155. Nuovo Biologics Recent Developments
Table 156. UBI Company Details
Table 157. UBI Business Overview
Table 158. UBI Veterinary Vaccines Product
Table 159. UBI Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million)
Table 160. UBI Recent Developments
Table 161. Valneva Company Details
Table 162. Valneva Business Overview
Table 163. Valneva Veterinary Vaccines Product
Table 164. Valneva Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million)
Table 165. Valneva Recent Developments
Table 166. Vetoquinol Company Details
Table 167. Vetoquinol Business Overview
Table 168. Vetoquinol Veterinary Vaccines Product
Table 169. Vetoquinol Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million)
Table 170. Vetoquinol Recent Developments
Table 171. Virbac Company Details
Table 172. Virbac Business Overview
Table 173. Virbac Veterinary Vaccines Product
Table 174. Virbac Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million)
Table 175. Virbac Recent Developments
Table 176. Research Programs/Design for This Report
Table 177. Key Data Information from Secondary Sources
Table 178. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Veterinary Vaccines Market Share by Type: 2021 VS 2028
Figure 2. Inactivated Vaccines Features
Figure 3. Live Attenuated Vaccines Features
Figure 4. Conjugate Vaccines Features
Figure 5. Toxoid Vaccines Features
Figure 6. Recombinant Vaccines Features
Figure 7. DNA Vaccines Features
Figure 8. Others Features
Figure 9. Global Veterinary Vaccines Market Share by Application: 2021 VS 2028
Figure 10. Veterinary Clinic Case Studies
Figure 11. Veterinary Hospital Case Studies
Figure 12. Veterinary Research Institute Case Studies
Figure 13. Retail Pharmacy Case Studies
Figure 14. Others Case Studies
Figure 15. Veterinary Vaccines Report Years Considered
Figure 16. Global Veterinary Vaccines Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 17. Global Veterinary Vaccines Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 18. Global Veterinary Vaccines Market Share by Region: 2021 VS 2028
Figure 19. Global Veterinary Vaccines Market Share by Players in 2021
Figure 20. Global Top Veterinary Vaccines Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Veterinary Vaccines as of 2021)
Figure 21. The Top 10 and 5 Players Market Share by Veterinary Vaccines Revenue in 2021
Figure 22. North America Veterinary Vaccines Market Size YoY (2017-2028) & (US$ Million)
Figure 23. North America Veterinary Vaccines Market Size Market Share by Type (2017-2028)
Figure 24. North America Veterinary Vaccines Market Size Market Share by Application (2017-2028)
Figure 25. North America Veterinary Vaccines Market Size Share by Country (2017-2028)
Figure 26. United States Veterinary Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Canada Veterinary Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Europe Veterinary Vaccines Market Size YoY (2017-2028) & (US$ Million)
Figure 29. Europe Veterinary Vaccines Market Size Market Share by Type (2017-2028)
Figure 30. Europe Veterinary Vaccines Market Size Market Share by Application (2017-2028)
Figure 31. Europe Veterinary Vaccines Market Size Share by Country (2017-2028)
Figure 32. Germany Veterinary Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. France Veterinary Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. U.K. Veterinary Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Italy Veterinary Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Russia Veterinary Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Nordic Countries Veterinary Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Asia-Pacific Veterinary Vaccines Market Size YoY (2017-2028) & (US$ Million)
Figure 39. Asia Pacific Veterinary Vaccines Market Size Market Share by Type (2017-2028)
Figure 40. Asia Pacific Veterinary Vaccines Market Size Market Share by Application (2017-2028)
Figure 41. Asia Pacific Veterinary Vaccines Market Size Share by Region (2017-2028)
Figure 42. China Veterinary Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Japan Veterinary Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. South Korea Veterinary Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Southeast Asia Veterinary Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. India Veterinary Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Australia Veterinary Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 48. Latin America Veterinary Vaccines Market Size YoY (2017-2028) & (US$ Million)
Figure 49. Latin America Veterinary Vaccines Market Size Market Share by Type (2017-2028)
Figure 50. Latin America Veterinary Vaccines Market Size Market Share by Application (2017-2028)
Figure 51. Latin America Veterinary Vaccines Market Size Share by Country (2017-2028)
Figure 52. Mexico Veterinary Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. Brazil Veterinary Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. Middle East & Africa Veterinary Vaccines Market Size YoY (2017-2028) & (US$ Million)
Figure 55. Middle East and Africa Veterinary Vaccines Market Size Market Share by Type (2017-2028)
Figure 56. Middle East and Africa Veterinary Vaccines Market Size Market Share by Application (2017-2028)
Figure 57. Middle East and Africa Veterinary Vaccines Market Size Share by Country (2017-2028)
Figure 58. Turkey Veterinary Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 59. Saudi Arabia Veterinary Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 60. UAE Veterinary Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 61. Elanco Revenue Growth Rate in Veterinary Vaccines Business (2017-2022)
Figure 62. Merck Revenue Growth Rate in Veterinary Vaccines Business (2017-2022)
Figure 63. Merial Revenue Growth Rate in Veterinary Vaccines Business (2017-2022)
Figure 64. Zoetis Revenue Growth Rate in Veterinary Vaccines Business (2017-2022)
Figure 65. Advaxis Revenue Growth Rate in Veterinary Vaccines Business (2017-2022)
Figure 66. AmpliPhi Biosciences Revenue Growth Rate in Veterinary Vaccines Business (2017-2022)
Figure 67. Aratana Therapeutics Revenue Growth Rat

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Classical Swine Fever Vaccines Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 100

It is a type of vaccine for classical swine fever. Classical swine fever (CSF), also known as hog cholera, is a contagious viral disease of pigs, including wild boar. The causative virus is a member of The genus Pestivirus of The family Flaviviridae, and is closely related to The viruses of bovine viral diarrhoea and border disease. There is only one serotype of CSF virus (CSFV). The global Classical Swine Fever Vaccines market was valued at US$ 154.7 million in 2023 and is anticipa......

Global Tylosin Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 96

According to our LPI (LP Information) latest study, the global Tylosin market size was valued at US$ 674.4 million in 2023. With growing demand in downstream market, the Tylosin is forecast to a readjusted size of US$ 909 million by 2030 with a CAGR of 4.4% during review period. The research report highlights the growth potential of the global Tylosin market. Tylosin are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chai......

Global Animal Parasiticides Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 106

According to our LPI (LP Information) latest study, the global Animal Parasiticides market size was valued at US$ 6898.6 million in 2023. With growing demand in downstream market, the Animal Parasiticides is forecast to a readjusted size of US$ 9363.4 million by 2030 with a CAGR of 4.5% during review period. The research report highlights the growth potential of the global Animal Parasiticides market. Animal Parasiticides are expected to show stable growth in the future market. However, ......

Global Newcastle Disease Vaccine Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 114

According to our LPI (LP Information) latest study, the global Newcastle Disease Vaccine market size was valued at US$ 308 million in 2023. With growing demand in downstream market, the Newcastle Disease Vaccine is forecast to a readjusted size of US$ 389.8 million by 2030 with a CAGR of 3.4% during review period. The research report highlights the growth potential of the global Newcastle Disease Vaccine market. Newcastle Disease Vaccine are expected to show stable growth in the future m......

Global Classical Swine Fever Vaccines Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 126

According to our LPI (LP Information) latest study, the global Classical Swine Fever Vaccines market size was valued at US$ 151.4 million in 2023. With growing demand in downstream market, the Classical Swine Fever Vaccines is forecast to a readjusted size of US$ 209.8 million by 2030 with a CAGR of 4.8% during review period. The research report highlights the growth potential of the global Classical Swine Fever Vaccines market. Classical Swine Fever Vaccines are expected to show stable ......

Global Veterinary Vaccine Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 151

According to our LPI (LP Information) latest study, the global Veterinary Vaccine market size was valued at US$ 10570 million in 2023. With growing demand in downstream market, the Veterinary Vaccine is forecast to a readjusted size of US$ 17200 million by 2030 with a CAGR of 7.2% during review period. The research report highlights the growth potential of the global Veterinary Vaccine market. Veterinary Vaccine are expected to show stable growth in the future market. However, product di......

Global Foot and Mouth Disease (FMD) Vaccines Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 134

According to our LPI (LP Information) latest study, the global Foot and Mouth Disease (FMD) Vaccines market size was valued at US$ 895.6 million in 2023. With growing demand in downstream market, the Foot and Mouth Disease (FMD) Vaccines is forecast to a readjusted size of US$ 1644.2 million by 2030 with a CAGR of 9.1% during review period. The research report highlights the growth potential of the global Foot and Mouth Disease (FMD) Vaccines market. Foot and Mouth Disease (FMD) Vaccines......

Global Veterinary Products for Companion Animals Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 109

According to our LPI (LP Information) latest study, the global Veterinary Products for Companion Animals market size was valued at US$ 15190 million in 2023. With growing demand in downstream market, the Veterinary Products for Companion Animals is forecast to a readjusted size of US$ 22710 million by 2030 with a CAGR of 5.9% during review period. The research report highlights the growth potential of the global Veterinary Products for Companion Animals market. Veterinary Products for Co......

Global Newcastle Disease Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 115

According to our (Global Info Research) latest study, the global Newcastle Disease Vaccine market size was valued at USD 323.9 million in 2023 and is forecast to a readjusted size of USD 402.7 million by 2030 with a CAGR of 3.2% during review period. Newcastle disease is a contagious viral bird disease affecting many domestic and wild avian species; it is transmissible to humans. Newcastle disease can be controlled by the use of vaccines. There are many Newcastle disease vaccines s......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs